Why Patients should be involved in health technology assessment

Janet Wale, Anna Mae Scott, Bjørn Hofmann, Sarah Garner, Eric Low, Lloyd Sansom

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

OBJECTIVES: Some countries make considerable effort to involve patients and patient groups in their health technology assessment (HTA) processes; others are only just considering or are yet to consider patient involvement in HTA.

METHODS: This commentary offers four arguments why patient involvement should be prioritized by those HTA agencies that do not yet involve patients: (1) from a patients' rights perspective, (2) based on patient and community values, (3) centering on evidentiary contributions, and (4) from a methodological perspective.

RESULTS: The first argument builds on the Alma-Ata Declaration, which holds that patients have a right and duty to have a say in the planning and delivery of their health care, individually and collectively. Where HTA is used to determine access to technologies and services, we argue that patients have a right to be heard. The second argues that decisions about treatments and services need to be aligned with the core values and morals of the patients whom the health system serves. The third argues that patients have unique knowledge and insights about living with a health condition and their needs for services and treatments regarding that condition, which can add to the knowledge base and value of the HTA process. The fourth argues that involvement of patients can facilitate methodological advancement of HTA, in areas such as early scientific advice and managed entry with evidence development.

CONCLUSIONS: An HTA process that includes patient perspectives can, therefore, provide added value to patients, policy makers and healthcare professionals alike.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalInternational Journal of Technology Assessment in Health Care
Volume33
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Biomedical Technology Assessment
Patient Participation
Delivery of Health Care
Knowledge Bases
Health
Patient Rights
Administrative Personnel

Cite this

Wale, Janet ; Scott, Anna Mae ; Hofmann, Bjørn ; Garner, Sarah ; Low, Eric ; Sansom, Lloyd. / Why Patients should be involved in health technology assessment. In: International Journal of Technology Assessment in Health Care. 2017 ; Vol. 33, No. 1. pp. 1-4.
@article{040a4d9dade74798893e496e41ecef13,
title = "Why Patients should be involved in health technology assessment",
abstract = "OBJECTIVES: Some countries make considerable effort to involve patients and patient groups in their health technology assessment (HTA) processes; others are only just considering or are yet to consider patient involvement in HTA.METHODS: This commentary offers four arguments why patient involvement should be prioritized by those HTA agencies that do not yet involve patients: (1) from a patients' rights perspective, (2) based on patient and community values, (3) centering on evidentiary contributions, and (4) from a methodological perspective.RESULTS: The first argument builds on the Alma-Ata Declaration, which holds that patients have a right and duty to have a say in the planning and delivery of their health care, individually and collectively. Where HTA is used to determine access to technologies and services, we argue that patients have a right to be heard. The second argues that decisions about treatments and services need to be aligned with the core values and morals of the patients whom the health system serves. The third argues that patients have unique knowledge and insights about living with a health condition and their needs for services and treatments regarding that condition, which can add to the knowledge base and value of the HTA process. The fourth argues that involvement of patients can facilitate methodological advancement of HTA, in areas such as early scientific advice and managed entry with evidence development.CONCLUSIONS: An HTA process that includes patient perspectives can, therefore, provide added value to patients, policy makers and healthcare professionals alike.",
author = "Janet Wale and Scott, {Anna Mae} and Bj{\o}rn Hofmann and Sarah Garner and Eric Low and Lloyd Sansom",
year = "2017",
month = "1",
day = "1",
doi = "10.1017/S0266462317000241",
language = "English",
volume = "33",
pages = "1--4",
journal = "International Journal of Technology Assessment in Health Care",
issn = "0266-4623",
publisher = "Cambridge University Press",
number = "1",

}

Why Patients should be involved in health technology assessment. / Wale, Janet; Scott, Anna Mae; Hofmann, Bjørn; Garner, Sarah; Low, Eric; Sansom, Lloyd.

In: International Journal of Technology Assessment in Health Care, Vol. 33, No. 1, 01.01.2017, p. 1-4.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Why Patients should be involved in health technology assessment

AU - Wale, Janet

AU - Scott, Anna Mae

AU - Hofmann, Bjørn

AU - Garner, Sarah

AU - Low, Eric

AU - Sansom, Lloyd

PY - 2017/1/1

Y1 - 2017/1/1

N2 - OBJECTIVES: Some countries make considerable effort to involve patients and patient groups in their health technology assessment (HTA) processes; others are only just considering or are yet to consider patient involvement in HTA.METHODS: This commentary offers four arguments why patient involvement should be prioritized by those HTA agencies that do not yet involve patients: (1) from a patients' rights perspective, (2) based on patient and community values, (3) centering on evidentiary contributions, and (4) from a methodological perspective.RESULTS: The first argument builds on the Alma-Ata Declaration, which holds that patients have a right and duty to have a say in the planning and delivery of their health care, individually and collectively. Where HTA is used to determine access to technologies and services, we argue that patients have a right to be heard. The second argues that decisions about treatments and services need to be aligned with the core values and morals of the patients whom the health system serves. The third argues that patients have unique knowledge and insights about living with a health condition and their needs for services and treatments regarding that condition, which can add to the knowledge base and value of the HTA process. The fourth argues that involvement of patients can facilitate methodological advancement of HTA, in areas such as early scientific advice and managed entry with evidence development.CONCLUSIONS: An HTA process that includes patient perspectives can, therefore, provide added value to patients, policy makers and healthcare professionals alike.

AB - OBJECTIVES: Some countries make considerable effort to involve patients and patient groups in their health technology assessment (HTA) processes; others are only just considering or are yet to consider patient involvement in HTA.METHODS: This commentary offers four arguments why patient involvement should be prioritized by those HTA agencies that do not yet involve patients: (1) from a patients' rights perspective, (2) based on patient and community values, (3) centering on evidentiary contributions, and (4) from a methodological perspective.RESULTS: The first argument builds on the Alma-Ata Declaration, which holds that patients have a right and duty to have a say in the planning and delivery of their health care, individually and collectively. Where HTA is used to determine access to technologies and services, we argue that patients have a right to be heard. The second argues that decisions about treatments and services need to be aligned with the core values and morals of the patients whom the health system serves. The third argues that patients have unique knowledge and insights about living with a health condition and their needs for services and treatments regarding that condition, which can add to the knowledge base and value of the HTA process. The fourth argues that involvement of patients can facilitate methodological advancement of HTA, in areas such as early scientific advice and managed entry with evidence development.CONCLUSIONS: An HTA process that includes patient perspectives can, therefore, provide added value to patients, policy makers and healthcare professionals alike.

UR - http://www.scopus.com/inward/record.url?scp=85020824321&partnerID=8YFLogxK

U2 - 10.1017/S0266462317000241

DO - 10.1017/S0266462317000241

M3 - Article

VL - 33

SP - 1

EP - 4

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

SN - 0266-4623

IS - 1

ER -